Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors()

Patient-derived xenograft (PDX) tumor models have emerged as a new approach to evaluate the effects of cancer drugs on patients’ personalized tumor grafts enabling to select the best treatment for the cancer patient and providing a new tool for oncology drug developers. Here, we report that human tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Bondarenko, Gennadiy, Ugolkov, Andrey, Rohan, Stephen, Kulesza, Piotr, Dubrovskyi, Oleksii, Gursel, Demirkan, Mathews, Jeremy, O’Halloran, Thomas V., Wei, Jian J., Mazar, Andrew P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611072/
https://www.ncbi.nlm.nih.gov/pubmed/26476081
http://dx.doi.org/10.1016/j.neo.2015.09.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611072/
https://www.ncbi.nlm.nih.gov/pubmed/26476081
http://dx.doi.org/10.1016/j.neo.2015.09.004

Ejemplares similares